NCT06287398
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
- Locations
-
- Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia
Clinical trial condition
Histiocytic Disorders, Malignant
Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.
260 public trials
43 recruiting studies
Histiocytic Disorders, Malignant trial results
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Incyte Biosciences Italy S.r.l Milan, Italy
NCT06006403
- Conditions
- Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), +16 more
- Locations
-
- Shanxi Bethune Hospital Taiyuan, Shanxi, China
Enrolling by Invitation
Long-term Study to Evaluate Safety and Persistence of GF-CART01
NCT06985576
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma (FL), +14 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Not Yet Recruiting
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma
NCT07677813
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China
NCT07443137
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +5 more
- Locations
-
Not specified
Not Yet Recruiting
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT07570823
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
Not Yet Recruiting
Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP
NCT07552324
- Conditions
- DHL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +7 more
- Locations
-
Not specified
Not Yet Recruiting
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping
NCT07511114
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Double Expressor Lymphoma, +6 more
- Locations
-
- No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai Shanghai, China
Not Yet Recruiting
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
NCT07472621
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China